Contrarius Group Holdings’s CRISPR Therapeutics CRSP Stock Holding History

Contrarius Group Holdings’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$18.2M	Buy
2025 Q1	$11.3M	Sell
2024 Q4	$14.5M	Buy